Fundz

Albert David Appoints Amit Mahla as Chief Executive Officer

PRIVATEAug 29, 2026

Position

Chief Executive Officer

Company

Albert David

Amit Mahla
BiotechnologyHealth CarePharmaceutical

Description

Amit Mahla has been appointed as the Whole-time Director and Chief Executive Officer of Albert David for a five-year term starting June 19, 2026. The decision was made during the 87th Annual General Meeting where high shareholder participation was noted.

Quick answer

Albert David Appoints Amit Mahla as Chief Executive Officer (August 29, 2026).

Who is the new Chief Executive Officer at Albert David?
Albert David named Amit Mahla Chief Executive Officer, announced August 29, 2026.
What did Albert David announce on August 29, 2026?
Amit Mahla has been appointed as the Whole-time Director and Chief Executive Officer of Albert David for a five-year term starting June 19, 2026. The decision was made during the 87th Annual General Meeting where high shareholder participation was noted.
What does Albert David do?
Albert David is a company focused on providing pharmaceutical and healthcare solutions.
Which similar companies made leadership changes around the same time?
Azora Therapeutics, Inc. (DE) (August 29, 2026), Inventiva (August 31, 2026), Arletta Pharma Solutions (September 1, 2026) and Parabilis Medicines (August 25, 2026) also announced leadership changes within 45 days of Albert David.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Albert David, and when

A new leader at Albert David brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Albert David raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Albert David, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Albert David. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Albert David

About

Albert David is a company focused on providing pharmaceutical and healthcare solutions. The company emphasizes high-quality products and innovative healthcare services. With a strong commitment to excellence, it aims to enhance the well-being of its customers. Established for several years, the company has built a reputable presence in its industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Albert David changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Albert David's next move

Learn about Strategic plan

Albert David changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.